FRM
NUVB icon

Fox Run Management’s Nuvation Bio NUVB Stock Holding History

Fox Run Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$185K Buy
+45,586
New +$254K 0.03% 777

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fox Run Management's NUVB Position: Q1 2026 in Review

Fox Run Management opened a new position in Nuvation Bio (NUVB) in Q1 2026: 45,586 shares worth $185K. The stake represents 0.03% of the portfolio and ranks #777 among its holdings.

231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Fox Run Management held 45,586 shares of Nuvation Bio worth $185K as of Q1 2026.
  • Nuvation Bio was a new Fox Run Management position in Q1 2026.
  • Nuvation Bio made up 0.03% of Fox Run Management's portfolio in Q1 2026, its #777 holding.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Fox Run Management's 13F filing for Q1 2026, filed 12 May 2026.